Initial information regarding this unsolicited case from United States was received from a healthcare professional 
on 10-Dec-2015.
This case concerns a female patient of unspecified age who attempted suicide unspecified time after receiving 
alirocumab (Praluent).
She had a history of depression and was taking antidepressant medications. No past drugs or concurrent 
conditions were reported.
On an unspecified date, the patient commenced therapy with alirocumab (dose, form, route, frequency, lot/batch 
number and expiration date not reported) for not reported indication delivered via alirocumab prefilled pen.
An unspecified time later, on an unknown date, the patient committed suicide. Reportedly, the patient had received 
Print Time: 13-JAN-2016 09:47 AM If a field is blank, there is no data for that field Page 32 of 34
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
six previous doses of alirocumab. She did state that this event has likely been previously reported.
Outcome: fatal.